61. HighWire -- Browse Journals - Myelodysplastic Syndromes Browse Journals publishing on myelodysplastic syndromes, (return to Topic Journals focusing on myelodysplastic syndromes (in order by highest focus) http://highwire.stanford.edu/lists/topic_dir/608683/608684/613947/613948/614293/

ANNOUNCEMENT: CHECK OUT THE PREVIEW RELEASE OF OUR NEW WEB SITE! My Favorite Journals ( HW-hosted journals HW-hosted Medline Author: Keyword(s): Year: Vol: Page: Home Adv. Search For Institutions For Publishers ... Sign in or register for access to all HighWire Press customization features Browse Journals publishing on Myelodysplastic Syndromes: (return to Topic List page) Myelodysplastic Syndromes Chronic Myelomonocytic Leukemia (CMML) Refractory Anemia Sort by: Alphabet Frequency of articles in Myelodysplastic Syndromes Focus of journal on Myelodysplastic Syndromes What's this? Journals focusing on Myelodysplastic Syndromes (in order by highest focus) ASH Education Program Book info free SITE Journal of Medical Genetics ... Hematologic Cancers and Related Disorders Myelodysplastic Syndromes Home Adv. Search For Institutions For Publishers ... partners/suppliers

62. Search Result For "Myelodysplastic Syndromes" Aplastic Anemia and myelodysplastic syndromes; Myelodysplasia; Myelodysplastic What is Myelodysplastic Syndrome?; Do We Know What Causes Myelodysplastic http://www.noah-health.org/search/results.php?lang=1&keyword=Myelodysplastic Syn

63. Anomalies ClassifMDSID1239 The concept of myelodysplastic syndromes has evolved gradually from the description Proposals for the classification of the myelodysplastic syndromes. http://www.infobiogen.fr/services/chromcancer/Anomalies/ClassifMDSID1239.html

Atlas of Genetics and Cytogenetics in Oncology and Haematology Home Genes Leukemias Solid Tumours ... NA Classification of myelodysplasic syndromes Identity Note Basis of classification in conformity with WHO recommandations. The classification of acute myeloid leukemia (AML) and myelodysplasic syndromes (MDS) includes clinical data (previous history, age) and biologic characteristics (morphology, cytochemistry, immunophenotype, cytogenetic and molecular biology). The separation of homogeneous classes allows us to distinguish pronostic parameters and to identify groups of patients sensitive to drugs or to specific treatment. Recurrent cytogenetic abnormalities are strong prognostic indicators in AML and MDS. Molecular studies of structural chromosomal changes have enabled the cloning of genes located at chromosomal breakpoints and have helped to characterize the proteins involved in leukemogenesis. Morphologic studies remain important because of a strong correlation with cytogenetic and molecular abnormalities. Clinics and Pathology Note The myelodysplastic syndromes (MDS) are clonal hematopoietic disorders characterized by cytopenia and bone marrow dysplasia. This is resulting from proliferation, differentiation and apoptotic processes of hematopoietic precursors with frequent evolution to acute myeloid leukemia (AML). Anemia, neutropenia or thrombocytopenia, separated or in combination, despite a hyper or normo-cellular bone marrow, define MDS. The concept of myelodysplastic syndromes has evolved gradually from the description of a group of anemias previously described as "refractory anemias".

64. Anomalies ChildMDS myelodysplastic syndromes in childhood. Report of 21 patients from Italy myelodysplastic syndromes in childhood a population based study of nine cases. http://www.infobiogen.fr/services/chromcancer/Anomalies/childMDS.html

Atlas of Genetics and Cytogenetics in Oncology and Haematology Home Genes Leukemias Solid Tumours ... NA Childhood myelodysplastic syndromes Clinics and Pathology Disease very heterogeneous: I- idiopathic MDS II- secondary MDS: to previous chemo- and/or radio-therapy III- 'genetic MDS': cases associated with a congenital genetic disease, such as: neurofibromatosis type 1 (Von Recklinhausen) (MIM 16220): an hamartoneoplastic syndrome Kostmann syndrome (MIM 20270): also called congenital neutropenia Bloom syndrome (MIM 21090): a chromosome instability syndrome Dubowitz syndrome (MIM 22337): mimicks Bloom's, but without chromosome instability Fanconi anaemia (MIM 22765): a chromosome instability syndrome -Schwachman syndrome (MIM 26040): with pancreatic insufficiency, and risksof leukaemia -Pearson disease (MIM 26056) and other mitochondrial diseases: they often share pancreatic insufficiency, bone marrow pancytopenia with myelodysplastic features but maintained polyclonality, muscular and other ubiquitous manifestations -familial monosomy 7 -familial platelet storage pool deficiency -unbalanced constitutional karyotypes, including +21, +8,del(11q), del(21q) miscellaneous conditions.

65. Myelodysplastic Syndromes - Cambridge University Press The chapters cover all aspects of the myelodysplastic syndromes, Clinical andprognostic characterization of Myelodysplastic Syndrome Peter Greenberg; http://www.cambridge.org/uk/catalogue/catalogue.asp?isbn=0521496683

66. Elsevier.com - Myelodysplastic Syndrome And Cytokines Myelodysplastic syndrome (MDS) is thought to be an incurable disease typified by Possible pathophysiological roles of GCSF in myelodysplastic syndromes http://www.elsevier.com/wps/product/librarians/522353

Home Site map Regional Sites Advanced Product Search ... Myelodysplastic Syndrome and Cytokines Book information Product description Author information and services Ordering information Bibliographic and ordering information Conditions of sale Book related information Submit your book proposal Other books in same subject area About Elsevier Select your view MYELODYSPLASTIC SYNDROME AND CYTOKINES Proceedings of the International Symposium, Sapporo, Japan, 28-29 September 1990 Edited by T. Miyazaki F. Takaku H. Uchino Included in series International Congress Series, 956 Description Myelodysplastic syndrome (MDS) is thought to be an incurable disease typified by a clonal disorder in the maturation and proliferation stage of multipotential hematopoietic stem cells. The three main themes in this book are: Influence of cytokines on the maturation and proliferation of normal hematopoietic progenitor cells as well as leukemic cells including those from patients with MDS. Synergisms of cytokines in vitro and in vivo. Clinical features of MDS including BMT. The book provides useful information regarding effective treatments of MDS based on a better understanding of the cytokine actions as well as the association with the hematopoiesis including the network system. Contents Effects of cytokines on hematopoietic progenitor cells and hematopoiesis.

67. Cancer Symptoms Treatments - Dana-Farber Cancer Institute Secondary myelodysplastic syndromes develop following treatment with radiation There are treatments for all patients with myelodysplastic syndromes. http://www.dana-farber.org/can/cancer/Default.asp?doc=CDR62723.xml&type=summary&

68. Methodist Healthcare - Services April 2005, Dacogen™ Effective in myelodysplastic syndromes. January 2005,Vidaza™ Approved for myelodysplastic syndromes http://www.methodisthealth.org/service.asp?id=canCin&fid=MedicalServices&CC_OB=_

69. Myelodysplastic Syndrome Lewis S, Wainscoat JS, Moore NR, Golding SJ. Magnetic resonance imaging inmyelodysplastic syndromes. Br J Radiol 1995 Feb;68(806)1217 UI95253709 http://home.earthlink.net/~radiologist/tf/031300.htm

This 77 y/o female presented with left hip pain and anemia after a fall. Plain films demonstrated some degenerative osteoarthritic changes but were otherwise unremarkable. An MRI with coronal T1 and fat saturated inversion recovery and axial proton density and fat saturated T2 weighted sequences was performed. Selected images from the MRI scan shown above demonstrate diffuse abnormal marrow signal and abnormal signal in the obturator internus. The abnormal signal in the obturator was felt to be due to muscle strain and was likely the cause of the acute left hip symptoms. Bone marrow biopsy and subsequent consultation with the Hematopathology Department at City of Hope National Medical Center with immunostains and expert morphologic review of peripheral blood and marrow led to the diagnosis of myelodysplastic syndrome. Lewis S, Wainscoat JS, Moore NR, Golding SJ. Magnetic resonance imaging in myelodysplastic syndromes. Br J Radiol 1995 Feb;68(806):121-7 UI:95253709 Takagi S, Tanaka O, Origasa H, Miura Y. Prognostic significance of magnetic resonance imaging of femoral marrow in patients with myelodysplastic syndromes. J Clin Oncol 1999 Jan;17(1):277-83 UI:99385425 Kusumoto S, Jinnai I, Matsuda A, Murohashi I, Bessho M, Saito M, Hirashima K, Heshiki A, Minamihisamatsu M. Bone marrow patterns in patients with aplastic anaemia and myelodysplastic syndrome: observations with magnetic resonance imaging. Eur J Haematol 1997 Sep;59(3):155-61 UI:97455911

70. Log In Problems The first drug in a new class of compounds shows promise for treating these commonhematologic disorders. http://www.medscape.com/viewarticle/509073?rss

71. LII - Results For "myelodysplastic Syndromes" The myelodysplastic syndromes Foundation. MDS, or myelodysplastic syndromes, isa collection of disorders in which the bone marrow does not produce enough http://www.lii.org/advanced?searchtype=subject;query=Myelodysplastic syndromes;s

72. HONmeeting - Health Conferences & Event- Myelodysplastic Syndromes Want more events about myelodysplastic syndromes in your mailbox? click here for myelodysplastic syndromes with HONselect. http://www.hon.ch/Conf/Theme/C15.378.190.625.html

HONcode sites All Web sites HONselect News ... Images Full text search: Date Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Theme Alphabet. Browse Location USA Europe Other Submit a conference ... Connecting Medical Informatics and Bio-Informatics 28 Aug - 1 Sept Geneva Switzerland Archive(s): " Internet in Health for All " Theme: A B C D ... Hemic and Lymphatic Diseases / Myelodysplastic Syndromes 27 Oct 29 Oct CME 3rd International Congress on Myeloproliferative Diseases and Myelodysplastic Syndromes USA CME - Continuing Medical Education Interested in advances on health and Internet applications? Visit: Want more events about Myelodysplastic Syndromes in your mailbox? click here Other Web resources (definition, articles, images, Web pages,...) for Myelodysplastic Syndromes with HONselect The keywords used on this page are the Medical Subject Headings developed by the National Library of Medicine®, USA Version française Home About us Site map ... Contact http://www.hon.ch/Conf/Theme/C15.378.190.625.html Last modified: Wed Sep 7 2005

73. ASH Image Bank - Case Study Myelodysplastic Syndrome. Atlas image, Stanley Schrier Achievements inUnderstanding and Treatment of myelodysplastic syndromes http://www.ashimagebank.org/fullcase.asp?case_id=100508

74. Myelodysplastic Syndromes And Myeloproliferative Disorders; Free, Interactive Te The Leukemia Lymphoma Society, the leading source of information and supportfor patients battling leukemia, lymphoma and myeloma, in collaboration with http://www.medicalnewstoday.com/medicalnews.php?newsid=12379

75. Clinical Trial: Infliximab In Treating Patients With Myelodysplastic Syndrome de novo myelodysplastic syndromes secondary myelodysplastic syndromes previouslytreated myelodysplastic syndromes, Drug infliximab http://www.clinicaltrials.gov/ct/gui/show/NCT00074074

Home Search Browse Resources ... About Infliximab in Treating Patients With Myelodysplastic Syndrome This study is currently recruiting patients. Verified by National Cancer Institute (NCI) May 2005 Sponsored by: European Organization for Research and Treatment of Cancer Information provided by: National Cancer Institute (NCI) ClinicalTrials.gov Identifier: Purpose RATIONALE: Monoclonal antibodies, such as infliximab, can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells. PURPOSE: Randomized phase II trial to study the effectiveness of infliximab in treating patients who have myelodysplastic syndrome. Condition Intervention Phase refractory anemia with excess blasts refractory anemia with ringed sideroblasts Refractory Anemia de novo myelodysplastic syndromes secondary myelodysplastic syndromes previously treated myelodysplastic syndromes Drug: infliximab Procedure: anti-cytokine therapy Procedure: anti-tumor necrosis factor therapy Procedure: antibody therapy Procedure: biological response modifier therapy Procedure: monoclonal antibody therapy Phase II MedlinePlus related topics: Anemia Bone Marrow Diseases Study Type: Interventional Study Design: Treatment Official Title: Phase II Randomized Study of Infliximab in Patients With Low- or Intermediate-Risk Myelodysplastic Syndromes Further Study Details: OBJECTIVES: Determine the therapeutic activity of 2 different doses of infliximab on peripheral blood cell count and peripheral and bone marrow blast cell count in patients with low- or intermediate-risk myelodysplastic syndromes.

76. Clinical Trial: Decitabine In Treating Patients With Myelodysplastic Syndromes O myelodysplastic and myeloproliferative disease myelodysplastic syndromes One of the following diagnoses; Highrisk myelodysplastic syndromes (MDS) http://www.clinicaltrials.gov/ct/gui/show/NCT00049582

Home Search Browse Resources ... About Decitabine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia This study is currently recruiting patients. Verified by National Cancer Institute (NCI) April 2005 Sponsors and Collaborators: Princess Margaret Hospital National Cancer Institute (NCI) Information provided by: National Cancer Institute (NCI) ClinicalTrials.gov Identifier: Purpose RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: This phase I trial is studying the side effects and best dose of decitabine in treating patients with myelodysplastic syndromes or acute myeloid leukemia. Condition Intervention Phase adult acute myeloid leukemia atypical chronic myeloid leukemia myelodysplastic and myeloproliferative disease Myelodysplastic Syndromes secondary acute myeloid leukemia Drug: decitabine Procedure: chemotherapy Phase I MedlinePlus related topics: Blood and Blood Disorders Bone Marrow Diseases Cancer Cancer Alternative Therapies ... Lymphatic Diseases Study Type: Interventional Study Design: Treatment Official Title: Phase I Study of Decitabine in Patients With High-Risk Myelodysplastic Syndromes or Acute Myeloid Leukemia Further Study Details: OBJECTIVES: Determine the maximum tolerated dose of decitabine in patients with high-risk myelodysplastic syndromes or acute myeloid leukemia.

77. BioMed Central | Full Text | Pediatric Myelodysplastic Syndromes myelodysplastic syndromes (MDS) are clonal disorders characterized by myelodysplastic syndromes with less than 5% blasts in the bone marrow are http://www.biomedcentral.com/1527-2729/6/209

home journals A-Z subject areas advanced search ... my BioMed Central To obtain access to Current Treatment Options in Oncology through your institution use the options below. If you would like information about a personal subscription, please contact subs@phl.cursci.com Click here to view an abstract of this article Click here to login if you are already a subscriber to Current Treatment Options in Oncology Subscribe to Current Treatment Options in Oncology Register for a free online trial Ask your librarian to investigate institutional access Athens users please click here to gain access If you believe you are seeing this page in error, or cannot activate your subscription, e-mail us info@biomedcentral.com Terms and Conditions Privacy statement Information for advertisers ... Contact us

78. BioMed Central | Full Text | New Agents In Myelodysplastic Syndromes To obtain access to Current Hematology Reports through your institution use theoptions below. If you would like information about a personal subscription, http://www.biomedcentral.com/1540-3408/4/191

home journals A-Z subject areas advanced search ... my BioMed Central To obtain access to Current Hematology Reports through your institution use the options below. If you would like information about a personal subscription, please contact subs@phl.cursci.com Click here to view an abstract of this article Click here to login if you are already a subscriber to Current Hematology Reports Subscribe to Current Hematology Reports Register for a free online trial Ask your librarian to investigate institutional access Athens users please click here to gain access If you believe you are seeing this page in error, or cannot activate your subscription, e-mail us info@biomedcentral.com Terms and Conditions Privacy statement Information for advertisers ... Contact us

79. PharmGKB: Myelodysplastic Syndromes Dysmyelopoietic Syndromes; Myelodysplastic Syndrome; Syndrome, Dysmyelopoietic;Syndrome, Myelodysplastic; Syndromes, Dysmyelopoietic; Syndromes, http://www.pharmgkb.org/do/serve?objId=PA445013&objCls=Disease

80. Disease Category Listing (516): Myelodysplastic Syndromes (MDS) CenterWatch Listing of Clinical Research Trials for myelodysplastic syndromes (MDS) http://www.centerwatch.com/patient/studies/cat516.html

Clinical Trials: Myelodysplastic Syndromes (MDS) California Bakersfield; Research Site A Study of Darbepoetin Alfa in Anemic Subjects with Low Risk Myelodysplastic Syndrome Berkeley; Research Site A Study of Darbepoetin Alfa in Anemic Subjects with Low Risk Myelodysplastic Syndrome Escondido; Research Site A Study of Darbepoetin Alfa in Anemic Subjects with Low Risk Myelodysplastic Syndrome Long Beach; Research Site A Study of Darbepoetin Alfa in Anemic Subjects with Low Risk Myelodysplastic Syndrome Los Angeles; Research Site A Study of Darbepoetin Alfa in Anemic Subjects with Low Risk Myelodysplastic Syndrome Murrieta; Research Site A Study of Darbepoetin Alfa in Anemic Subjects with Low Risk Myelodysplastic Syndrome Poway; Research Site A Study of Darbepoetin Alfa in Anemic Subjects with Low Risk Myelodysplastic Syndrome Rancho Mirage; Research Site A Study of Darbepoetin Alfa in Anemic Subjects with Low Risk Myelodysplastic Syndrome Santa Cruz; Research Site A Study of Darbepoetin Alfa in Anemic Subjects with Low Risk Myelodysplastic Syndrome Colorado Aurora; Research Site

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Page 4     61-80 of 102    Back | 1  | 2  | 3  | 4  | 5  | 6  | Next 20